These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21916024)

  • 21. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral fluid for the detection of drugs of abuse using immunoassay and LC-MS/MS.
    Moore C; Crouch D
    Bioanalysis; 2013 Jun; 5(12):1555-69. PubMed ID: 23795933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The recovery of illicit drugs from oral fluid sampling devices.
    Dickson S; Park A; Nolan S; Kenworthy S; Nicholson C; Midgley J; Pinfold R; Hampton S
    Forensic Sci Int; 2007 Jan; 165(1):78-84. PubMed ID: 16621382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Wood M; Laloup M; Ramirez Fernandez Mdel M; Jenkins KM; Young MS; Ramaekers JG; De Boeck G; Samyn N
    Forensic Sci Int; 2005 Jun; 150(2-3):227-38. PubMed ID: 15944064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-site drug testing.
    Drummer OH
    Bull Narc; 2005; 57(1-2):205-11. PubMed ID: 21338022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid drug detection in oral samples by porous silicon assisted laser desorption/ionization mass spectrometry.
    Lowe RD; Guild GE; Harpas P; Kirkbride P; Hoffmann P; Voelcker NH; Kobus H
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3543-8. PubMed ID: 19844964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioanalytical procedures for determination of drugs of abuse in oral fluid.
    Samyn N; Laloup M; De Boeck G
    Anal Bioanal Chem; 2007 Aug; 388(7):1437-53. PubMed ID: 17404716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
    Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D
    Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs of abuse detection in meconium: a comparison between ELISA and biochip microarray.
    Marin SJ; Merrell M; McMillin GA
    J Anal Toxicol; 2011 Jan; 35(1):40-5. PubMed ID: 21219702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of urine and hair testing for drugs of abuse in the control of abstinence in driver's license re-granting.
    Dufaux B; Agius R; Nadulski T; Kahl HG
    Drug Test Anal; 2012 Jun; 4(6):415-9. PubMed ID: 22447399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of drug concentrations between whole blood and oral fluid.
    Langel K; Gjerde H; Favretto D; Lillsunde P; Øiestad EL; Ferrara SD; Verstraete AG
    Drug Test Anal; 2014 May; 6(5):461-71. PubMed ID: 24039237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Anal Bioanal Chem; 2008 Jul; 391(6):2329-38. PubMed ID: 18483722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of an immunoassay screening cutoff concentration for opioids in oral fluid.
    Garnier M; Coulter C; Moore C
    J Anal Toxicol; 2011 Jul; 35(6):369-74. PubMed ID: 21740695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.